...
首页> 外文期刊>Breast Cancer Research >Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer
【24h】

Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer

机译:原发性肿瘤的相对微血管区域而不是淋巴结状态,预示了在临床非转移性乳腺癌患者中通过逆转录酶聚合酶链反应检测到的骨髓微转移的存在

获取原文
   

获取外文期刊封面封底 >>

       

摘要

About 50% of patients with breast cancer have no involvement of axillary lymph nodes at diagnosis and can be considered cured after primary locoregional treatment. However, about 20–30% will experience distant relapse. The group of patients at risk is not well characterised: recurrence is probably due to the establishment of micrometastases before treatment. Given the early steps of metastasis in which tumour cells interact with endothelial cells of blood vessels, and, given the independent prognostic value in breast cancer of both the quantification of tumour vascularisation and the detection of micrometastases in the bone marrow, the aim of this study was to determine the relationship between vascularisation, measured by Chalkley morphometry, and the bone marrow content of cytokeratin-19 (CK-19) mRNA, quantified by real-time reverse transcriptase polymerase chain reaction, in a series of 68 patients with localised untreated breast cancer. The blood concentration of factors involved in angiogenesis (interleukin-6 and vascular endothelial growth factor) and of factors involved in coagulation (D-dimer, fibrinogen, platelets) was also measured. When bone marrow CK-19 relative gene expression (RGE) was categorised according to the cut-off value of 0.77 (95th centile of control patients), 53% of the patients had an elevated CK-19 RGE. Patients with bone marrow micrometastases, on the basis of an elevated CK-19 RGE, had a mean Chalkley count of 7.5 ± 1.7 (median 7, standard error [SE] 0.30) compared with a mean Chalkley count of 6.5 ± 1.7 in other patients (median 6, SE 0.3) (Mann–Whitney U-test; P = 0.04). Multiple regression analysis revealed that Chalkley count, not lymph node status, independently predicted CK-19 RGE status (P = 0.04; odds ratio 1.38; 95% confidence interval 1.009–1.882). Blood parameters reflecting angiogenesis and coagulation were positively correlated with Chalkley count and/or CK-19 RGE. Our data are in support of an association between elevated relative microvessel area of the primary tumour and the presence of bone marrow micrometastases in breast cancer patients with operable disease, and corroborate the paracrine and endocrine role of interleukin-6 and the involvement of coagulation in breast cancer growth and metastasis.Keywords: angiogenesis, bone marrow, breast cancer, Chalkley, micrometastasis.
机译:约有50%的乳腺癌患者在诊断时没有腋窝淋巴结受累,可以在初次局部治疗后视为治愈。但是,大约20–30%的患者会复发。处于危险中的患者组的特征不明确:复发可能是由于治疗前微转移的建立。考虑到肿瘤细胞与血管内皮细胞相互作用的转移的早期步骤,并且考虑到肿瘤血管化的量化和骨髓微转移的检测在乳腺癌中的独立预后价值,本研究的目的确定在一系列未经治疗的68例乳腺癌局部患者中,通过Chalkley形态测定法测定的血管形成与通过实时逆转录酶聚合酶链反应定量的细胞角蛋白19(CK-19)mRNA的骨髓含量之间的关系癌症。还测量了涉及血管生成的因子(白介素6和血管内皮生长因子)和涉及凝血的因子(D-二聚体,纤维蛋白原,血小板)的血药浓度。当根据临界值0.77(对照患者的95%)对骨髓CK-19相对基因表达(RGE)进行分类时,有53%的患者CK-19 RGE升高。 CK-19 RGE升高的骨髓微转移患者的Chalkley平均计数为7.5±1.7(中位数7,标准误[SE] 0.30),而其他患者的Chalkley平均计数为6.5±1.7 (中位数6,SE 0.3)(Mann-Whitney U检验; P = 0.04)。多元回归分析显示,Chalkley计数而非淋巴结状态独立预测CK-19 RGE状态(P = 0.04;比值比1.38; 95%置信区间1.009-1.882)。反映血管生成和凝血的血液参数与Chalkley计数和/或CK-19 RGE正相关。我们的数据支持患有可手术疾病的乳腺癌患者中原发性肿瘤的相对微血管面积增加与骨髓微转移的存在之间的关联,并证实白细胞介素6的旁分泌和内分泌作用以及乳房中凝血的参与关键词:血管生成,骨髓,乳腺癌,Chalkley,微转移。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号